Format

Send to

Choose Destination
Am J Obstet Gynecol. 2005 Jul;193(1):58-63.

Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys.

Author information

1
Department of Obstetrics, Karolinska Hospital, Stockholm, Sweden and Comparative Medicine Clinical Research Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA. peter.conner@ks.se

Abstract

OBJECTIVE:

The purpose of this study was to analyze the expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys.

STUDY DESIGN:

Sixty oophorectomized macaques were randomized to receive tibolone, conjugated equine estrogens (CEE), CEE+medroxyprogesterone acetate (MPA), or no hormonal treatment. Breast tissue was collected at necropsy after 2 years, and stained for p53, p21, and cleaved caspase-3.

RESULTS:

Differences were seen between treatment groups. The expression of p53 and caspase-3 was significantly lower in tibolone-treated animals (P<.01). Levels of p53 and caspase-3 were lower in the combined treatment group (CEE+MPA) when compared to both estrogen only and control groups.

CONCLUSION:

Alternative regimens for hormonal therapy seem to have different effects on p53 expression and apoptotic activity within the breast. A combined effect of increased proliferation and decreased apoptosis could be one possible mechanism to explain an increased risk for breast cancer.

PMID:
16021059
DOI:
10.1016/j.ajog.2004.11.056
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center